Our findings revealed that interventions with sildenafil, furosemide, and their combined regimen, in both traditional and NP formulations, led to significant reductions in NGAL and KIM-1 concentrations in the glycerol-induced AKI model. This evidence concerns the gene HAVCR1 and acute kidney injury.